Browse available funds

The scope of support includes 
1. Facilitation for Patenting Activity
▪ Patent Search & Analysis (Patentability, Freedom-to-Operate (FTO), State of the Art Search, Patent  Landscape)
▪ Drafting, filing and prosecution of Patent applications in India (Provisional, Complete and in foreign  jurisdictions (Convention, PCT and National Phase).
2. Facilitation for Technology Transfer- The scope of support under facilitation for technology transfer includes Technology evaluation, Technology marketing, identification of potential industry for licensing and/or collaboration, Technology valuation, Negotiation, drafting of agreements and post-licensing monitoring. 

Requests/Applications for Patent facilitation shall be accepted through quarterly call announcements on the BIRAC website and all applications/requests are required to be submitted online only. 

Mode of funding is co-funding or Grant-in-Aid mode

By way of Co-Funding:
a) “Co-funding” mode for BIRAC-supported entities, Non-BIRAC supported entities and Private Research Institutions, with obligation to pay benefit sharing.
b) The Co-funding support for Patent facilitation under BIRAC-PATH shall be provided in the following manner:
70% (maximum) funding shall be borne by BIRAC and 30% (minimum) by grantee/Applicant towards Patent drafting, filing and prosecution in the requested jurisdictions till the grant of patent
 OR Commercialization in the territory of funding support availed, whichever is earlier

By way of Grant-in-aid funding:
a) “Grant-in-Aid funding” for the Government Institutes and Universities, with obligation to pay benefit sharing.
b) The Grant-in-Aid funding support for Patent facilitation under BIRAC-PATH shall be provided in the following manner: 100% funding shall be borne by BIRAC towards drafting, filing and prosecution in the requested jurisdictions till grant of the patent
OR Commercialization in the territory of funding support availed, whichever is earlier

Who can apply: Any registered startup with a working prototype or early pilot.

Selected 30 startups will get:
💰 ₹50 lakh convertible funding each — no priced round, no equity dilution upfront
🏆 Up to ₹1.5 cr additional at Demo Day
🔬 Labs & pilot sites at IIT Madras, IIT Kanpur, IIT Kharagpur, C-CAMP, Venture Center Pune and R&D centers of India’s energy majors.
🤝 Direct procurement pathways into ONGC, IOCL, HPCL, BPCL, GAIL, Oil India, Petronet LNG, EIL
🎯 Mentoring from premier institutes + industry experts

This Program shall apply to Startups and MSMEs engaged in the development of telecom and ICT solutions including, but not limited to, the following domains:
i. Communications (5G, 6G, Satellite, Navigation, etc.)
ii. Quantum Communication
iii. Semiconductors & Electronics
iv. Robotics (Drones, Humanoid, etc.)
v. Cybersecurity
vi. IoT, Wearables, AR/VR/Immersive Media 
vii. AI, IT & Software, Human Computer Interaction
viii.Use cases relating to Green Tech (Renewable Energy, Electric Vehicle, Autonomous Vehicle, etc.) and Services (FinTech, EdTech, HealthTech, E-commerce, etc.), subject to the condition that these use cases are explicitly linked to telecom network integration.

This call seeks to foster bilateral partnerships that accelerate the development and commercialization of transformative technologies and solutions with significant societal and economic impact in the areas of Critical Minerals & Supply Chain Resilience and Quantum Technologies.

The Marginal Investment Scheme for Reducing Import Dependence will be implemented over
a three-year period from FY 2024 to FY 2027, with a total budgetary allocation of ₹180 crore
to support eligible manufacturing projects across the medical device sector.
Projects approved under the Scheme shall be completed within two (2) years from the date of
final approval by the Scheme Steering Committee, with the final permissible completion date
being 31.3.2027.

Funds are released only after completion & commissioning of project and completion of other requirements. Funding is equivalent to 10–20% of project cost or max ₹10 Cr on reimbursement basis, post-completion.

This scheme covers animal studies, human clinical investigations, post‑market follow‑up studies, and clinical
performance evaluations of IVDs. 

The targeted beneficiaries include:

-Medical device manufacturers with a facility in India
- IVD manufacturers with Indian manufacturing
- National institutes (e.g., IITs, IISc, AIIMS, NIPERs)
These beneficiaries can conduct studies themselves or through CROs

Studies targeting rare diseases, national health issues, and high‑value import‑dependent devices receive priority.

Support to healthcare startups to close key gaps in tech development, de-risking & validation.

Bharat Water Innovation Network (Bharat WIN) is a national initiative oaimed at driving meaningful and technology-led transformation in India's water sector. 

This call is a part of the global Grand Challenges call on ‘Innovations in Cost-Disruptive Novel Tools for Screening and Diagnosis’ focusing on different priority areas and opportunities. The initiative under GC India seeks transformative, high-risk, high-reward innovations in the priority disease area, fundamentally rethinking how diagnosis or screening is performed, including novel sensing modalities, software-defined diagnostics, and AI-enabled or software-only approaches that materially change performance, cost structure, or deployment models.

For Startups, SMEs and Large industries.

Deep-tech innovations- TRL 4+

Co-investments funding: Rs.5 cr- 200 cr